Home›Corticosteroids›Corticosteroids + Ocrelizumab And Hyaluronidase

Does Corticosteroids Interact with Ocrelizumab And Hyaluronidase?

Corticosteroids and Ocrelizumab And Hyaluronidase have a moderate drug interaction according to U.S. FDA drug labeling data. Immunosuppressant doses of corticosteroids with ocrelizumab are expected to increase the risk of immunosuppression. Consider risk of additive immune system effects when coadministering. The mechanism involves additive immunosuppressive effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity: Moderate
Ocrelizumab And Hyaluronidase Class: Endoglycosidase
Management: Monitor for effects
Data Source: U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Corticosteroids and Ocrelizumab And Hyaluronidase occurs because additive immunosuppressive effects. Clinically, this means immunosuppressant doses of corticosteroids with ocrelizumab are expected to increase the risk of immunosuppression. consider risk of additive immune system effects when coadministering. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Corticosteroids and your doctor is considering prescribing Ocrelizumab And Hyaluronidase (or vice versa), make sure to:

Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
Ask whether the benefits of combining these medications outweigh the risks for your specific situation
Ask what symptoms to watch for that would indicate the interaction is causing problems
Ask whether any dosage adjustments are needed
Never stop or change either medication without first consulting your healthcare provider

💊 Corticosteroids(Neo-Polycin HC)+💊 Ocrelizumab And Hyaluronidase(Ocrevus Zunovo)

Severity & Interaction Details

🟡

moderate

Be aware — moderate interaction

Documented interaction with manageable risk. May require dose adjustment or monitoring.

Severity scale

MinorContra

On record

Yes

Drug A class

—

Drug B class

Endoglycosidase

Source

NLP:ocrelizumab and hyaluronidase

What this means in plain English

Immunosuppressant doses of corticosteroids with ocrelizumab are expected to increase the risk of immunosuppression. Consider risk of additive immune system effects when coadministering.

About Corticosteroids and Ocrelizumab And Hyaluronidase

Ocrelizumab And Hyaluronidase is an Endoglycosidase. You may recognize them by the brand names Neo-Polycin HC and Ocrevus Zunovo. Ocrelizumab And Hyaluronidase is given by injection under the skin.

What the FDA label says

"Additive immunosuppressive effects"

📖 Source: NLP:ocrelizumab and hyaluronidase

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

PubMed

Endophthalmitis caused by Shinella species: the first case report.about Corticosteroids · 2026-06

PubMed

Loeffler Endocarditis: Multimodality Imaging of a Common Cardiac Phenotype in Distinct Hypereosinophilic Syndromes.about Corticosteroids · 2026-06

PubMed

Nausea and Vomiting During Pregnancy.about Corticosteroids · 2026-06

Share this result:

WhatsApp Text / SMS Email

Also share on:X Facebook

Add more drugs

Check Corticosteroids and Ocrelizumab And Hyaluronidase against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.